Patent · US Active

Antigen binding polypeptides

US9221918B2 · kind B2 · utility

5Cited by
4References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 28, 2015
Grant dateDec 29, 2015
Priority date
Expiry dateJan 28, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to a platform technology for production of antigen binding polypeptides having specificity for a desired target antigen which is based on the conventional antibody repertoire of species in the family Camelidae, and to antigen binding polypeptides obtained using this technology platform. In particular, the invention provides an antigen binding polypeptide comprising a VH domain and a VL domain, wherein at least one hypervariable loop or complementarity determining region (CDR) in the VH domain or the VL domain is obtained from a VH or VL domain of a species in the family Camelidae.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.